Haas, Tobias Longin
 Distribuzione geografica
Continente #
NA - Nord America 1.193
EU - Europa 837
AS - Asia 438
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.472
Nazione #
US - Stati Uniti d'America 1.188
SE - Svezia 315
CN - Cina 262
IT - Italia 150
PL - Polonia 129
SG - Singapore 87
IE - Irlanda 68
ID - Indonesia 41
FR - Francia 29
UA - Ucraina 27
DE - Germania 26
RU - Federazione Russa 21
GB - Regno Unito 20
TR - Turchia 18
ES - Italia 17
BE - Belgio 12
IN - India 12
NL - Olanda 8
AT - Austria 6
VN - Vietnam 6
FI - Finlandia 5
HK - Hong Kong 4
CA - Canada 3
BR - Brasile 2
CH - Svizzera 2
IR - Iran 2
JP - Giappone 2
BG - Bulgaria 1
CL - Cile 1
DO - Repubblica Dominicana 1
EU - Europa 1
HR - Croazia 1
IQ - Iraq 1
LK - Sri Lanka 1
PK - Pakistan 1
PR - Porto Rico 1
TW - Taiwan 1
Totale 2.472
Città #
Chandler 175
Ashburn 153
Warsaw 129
Fairfield 99
Dublin 68
Singapore 64
Nanjing 61
Dearborn 56
Wilmington 52
Houston 45
Ann Arbor 41
Jakarta 41
Redmond 39
Princeton 38
Woodbridge 38
Cambridge 35
Jacksonville 34
Seattle 33
Cattolica 32
San Mateo 30
Rome 28
Los Angeles 21
Nanchang 21
Kunming 19
Beijing 17
Shenyang 17
Hebei 15
Izmir 15
Redwood City 15
Boston 14
Brussels 12
Moscow 12
New York 12
Shanghai 12
Donostia / San Sebastian 11
Chicago 10
Changsha 9
Tianjin 9
Washington 9
Guangzhou 8
Hefei 8
Hangzhou 7
Milan 7
Mountain View 7
Norwalk 7
Dong Ket 6
San Diego 6
Vienna 6
Bremen 5
London 5
Marseille 5
Santa Clara 5
Turin 5
Andover 4
Changchun 4
Falls Church 4
Gurgaon 4
Hong Kong 4
Sangüesa 4
Augusta 3
Boardman 3
Genoa 3
Jiaxing 3
Lanzhou 3
Paris 3
Zhengzhou 3
Catanzaro 2
Changshahsien 2
Chiswick 2
Crick 2
Edinburgh 2
Fort Worth 2
Frankfurt am Main 2
Fuzhou 2
Genova 2
Groningen 2
Gualdo Cattaneo 2
Harbin 2
Helsinki 2
Kocaeli 2
Madrid 2
Pace del Mela 2
Phoenix 2
Salò 2
San Francisco 2
San Jose 2
Toronto 2
Turku 2
Verona 2
Wuhan 2
Zurich 2
Acton 1
Amsterdam 1
Baghdad 1
Benevento 1
Bergamo 1
Brindisi 1
Chaoyang 1
Chengdu 1
Clifton 1
Totale 1.732
Nome #
The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells 256
Two-Step Co-Immunoprecipitation (TIP) Enables Efficient and Highly Selective Isolation of Native Protein-Complexes. 244
A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer 141
Inhibitor of integrin for the treatment or prevention of tumours 132
Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 108
LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis 97
Integrin a7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 96
Antitumor effect of miR-197 targeting in p53 wild-type lung cancer 86
Two-Step Co-Immunoprecipitation (TIP) 84
Two-Step Coimmunoprecipitation (TIP) enables efficient and highly selective isolation of native protein complexes 83
LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L 70
Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 66
Identification of Targets to Redirect CAR T Cells in Glioblastoma and Colorectal Cancer: An Arduous Venture 61
Bortezomib sensitizes primary meningioma cells to TRAIL-induced apoptosis by enhancing formation of the death-inducing signaling complex 56
Lung cancer stem cells: Tools and targets to fight lung cancer 53
Antitumor effect of miR-197 targeting in p53 wild-type lung cancer 53
LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis 51
The linear ubiquitin chain assembly complex (LUBAC) forms part of the TNF-R1 signalling complex and is required for effective TNF-induced gene induction and prevents TNF-induced apoptosis 49
Linear ubiquitination prevents inflammation and regulates immune signalling 47
CD95 co-stimulation blocks activation of naive T cells by inhibiting T cell receptor signaling 45
Apoptosis and Cancer Therapy: From Cutting-edge Science to Novel Therapeutic Concepts 43
Identification of Targets to Redirect CAR T Cells in Glioblastoma and Colorectal Cancer: An Arduous Venture 42
The autophagic protein FYCO1 controls TNFRSF10/TRAIL receptor induced apoptosis and is inactivated by CASP8 (caspase 8) 39
Biochemical analysis of the native TRAIL death-inducing signaling complex 37
Polymeric substrates with tunable elasticity and nanoscopically controlled biomolecule presentation 37
Apoptosis mediated by lentiviral TRAIL transfer involves transduction-dependent and -independent effects 37
Bortezomib sensitizes primary human astrocytoma cells of WHO grades I to IV for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis 35
Recruitment of the Linear Ubiquitin Chain Assembly Complex Stabilizes the TNF-R1 Signaling Complex and Is Required for TNF-Mediated Gene Induction 32
The PEA-15/PED protein protects glioblastoma cells from glucose deprivation-induced apoptosis via the ERK/MAP kinase pathway 32
Small molecule XIAP inhibitors enhance TRAIL-Lnduced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma 31
Regulation of Enterocyte Apoptosis by Acyl-CoA Synthetase 5 Splicing 30
Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo 29
TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer-specific apoptosis within a therapeutic window 28
Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis 27
Biochemical analysis of the native TRAIL death-inducing signaling complex 27
NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2 26
Enhanced caspase-8 recruitment to and activation at the disc is critical for sensitisation of human hepatocellular carcinoma cells to trail-induced apoptosis by chemotherapeutic drugs 26
Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptors 25
Proteasome inhibition sensitizes hepatocellular carcinoma cells, but not human hepatocytes, to TRAIL 23
Preclinical differentiation between apparently safe and potentially hepatotoxic applications of TRAIL either alone or in combination with chemotherapeutic drugs 23
Micro-nanostructured protein arrays: a tool for geometrically controlled ligand presentation 23
Totale 2.530
Categoria #
all - tutte 12.852
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.852


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020272 0 0 0 0 44 58 58 18 24 11 45 14
2020/2021186 12 13 24 8 36 11 18 5 14 15 20 10
2021/2022295 22 15 7 14 29 33 5 54 14 24 49 29
2022/2023645 124 102 65 58 59 67 25 44 61 11 18 11
2023/2024389 10 98 16 44 13 49 18 11 3 33 49 45
2024/2025170 22 20 68 25 35 0 0 0 0 0 0 0
Totale 2.530